Spironolactone Reduces the Risk of Low-Dose Oral Minoxidil-Induced Edema in Women with Female Pattern Hair Loss.

    February 2025 in “ Journal of the American Academy of Dermatology ”
    Juan ­Jimenez‐Cauhe, Rocío Gil‐Redondo, David Saceda‐Corralo … Sergio Vañó‐Galván
    Studysummary Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 10

    1. Oral Finasteride (5 mg and 2 mg) Versus Topical Minoxidil 5% in Female Pattern Hair Loss Clinical Dermatology Review · 2025
    2. Role Of Oral Minoxidil In The Treatment Of Androgenetic Alopecia Cosmoderma · 2024
    3. Spironolactone for Treatment of Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    4. 5% Minoxidil: Treatment for Female Pattern Hair Loss PubMed · 2015
    5. Therapy Of Androgenetic Alopecia In Women With Minoxidil Solution Gynäkologische Endokrinologie · 2009
    6. Treatment of Female Pattern Hair Loss with a Combination of Spironolactone and Minoxidil Australasian Journal of Dermatology · 2007
    7. Androgenetic Alopecia in Adolescents PubMed · 2003
    8. Effect of Minoxidil on Hair Growth in Androgenic Alopecia in Women PubMed · 2002
    9. A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia Journal of The American Academy of Dermatology · 1996
    10. The Use of Minoxidil to Prevent Alopecia During Chemotherapy for Gynecologic Malignancies PubMed · 1991